| Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 |
|---|
| Net income (loss) | -571 | -610 | -271 |
|---|
| Deferred taxes | -0 | -0 | 0 |
|---|
| Net realized loss (gain) on sale of financial instruments | 0 | -1 | -0 |
|---|
| Fair Value Adjustment of Warrants | 13 | - | - |
|---|
| Depreciation and amortization expense | 15 | 15 | 31 |
|---|
| Amortization of debt issuance costs | 0 | 1 | 1 |
|---|
| Stock-based compensation expense | 86 | 112 | 160 |
|---|
| Net amortization (accretion) of investments | -8 | -2 | 29 |
|---|
| Debt extinguishment loss | -20 | - | - |
|---|
| Provision for credit losses | - | - | 29 |
|---|
| Premiums and accounts receivable | 67 | 78 | 13 |
|---|
| Risk adjustment transfer receivable | 10 | 9 | 2 |
|---|
| Reinsurance recoverable | -147 | 461 | -652 |
|---|
| Other assets | 9 | 0 | -11 |
|---|
| Benefits payable | 202 | 424 | 28 |
|---|
| Unearned premiums | 3 | 4 | -13 |
|---|
| Premium deficiency reserve | -55 | -25 | 2 |
|---|
| Accounts payable and other liabilities | 99 | 58 | -29 |
|---|
| Reinsurance payable | -138 | 222 | -367 |
|---|
| Risk adjustment transfer payable | 78 | 723 | -461 |
|---|
| Net cash (used in) provided by operating activities | -182 | 380 | -272 |
|---|
| Purchase of investments | 1,810 | 1,193 | 837 |
|---|
| Sale of investments | 624 | 361 | 32 |
|---|
| Maturity of investments | 431 | 633 | 1,410 |
|---|
| Purchase of property, equipment and capitalized software | 26 | 29 | 26 |
|---|
| Change in restricted deposits | -7 | -1 | 2 |
|---|
| Net cash (used in) provided by investing activities | -775 | -227 | 577 |
|---|
| Proceeds from long-term debt | - | 305 | - |
|---|
| Payments of debt issuance costs | - | 7 | - |
|---|
| Proceeds from joint venture contribution | - | 2 | 2 |
|---|
| Debt extinguishment costs | 13 | - | - |
|---|
| Proceeds from Issuance Initial Public Offering | 1,348 | - | - |
|---|
| Offering costs from IPO | 9 | - | - |
|---|
| Proceeds from Warrant Exercises | 9 | - | - |
|---|
| Proceeds from Warrant Exercises | 9 | - | - |
|---|
| Proceeds from Noncontrolling Interests | 7 | - | - |
|---|
| Proceeds from Noncontrolling Interests | 7 | - | - |
|---|
| Proceeds from Stock Options Exercised | 50 | 1 | 4 |
|---|
| Proceeds from Stock Options Exercised | 50 | 1 | 4 |
|---|
| Net cash provided by financing activities | 1,239 | 301 | 6 |
|---|
| Net cash provided by financing activities | 1,239 | 301 | 6 |
|---|
| Increase in cash, cash equivalents and restricted cash equivalents | 282 | 455 | 311 |
|---|
| Interest payments | 4 | 10 | 23 |
|---|
| Income tax payments | 1 | 2 | 2 |
|---|
| Conversion of Stock, Amount Issued | 1,745 | - | - |
|---|
| Net Exercise of Preferred Stock Warrants to Common Stock | 28 | - | - |
|---|
| Fair Value Adjustment, Preferred Stock Warrant Liability | 13 | - | - |
|---|